阳光诺和：就STC008注射液项目签署技术开发合同

Group 1 - The core point of the article is that Yangguang Nuohuo (688621) has signed a cooperation agreement with Zhejiang Xinghao Holdings to jointly develop the STC008 injection project [1] - According to the technical development contract, the company will receive an initial payment of 50 million yuan and subsequent milestone payments, totaling 500 million yuan (including tax), along with an 8% sales share of the net sales (excluding tax) [1] - STC008 is a self-initiated research and development project by the company, primarily aimed at treating cancer cachexia in patients with advanced solid tumors, and is currently in the Phase I clinical trial stage [1]